Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1995 Sep;73(2):F99–102. doi: 10.1136/fn.73.2.f99

Effect of human colostrum on interleukin-2 production and natural killer cell activity.

L Sirota 1, R Straussberg 1, I Notti 1, H Bessler 1
PMCID: PMC2528498  PMID: 7583615

Abstract

The effect of human colostrum on the production of interleukin-2 (IL-2) and on natural killer (NK) cell activity by peripheral blood mononuclear cells (PBMC) was investigated in 50 healthy women. At concentrations as low as 0.5%, human colostrum stimulated IL-2 production; at a higher concentration (10%), IL-2 secretion was inhibited. A time and dose dependent inhibitory effect of colostrum on NK cytotoxicity was also observed. This inhibition could be reversed by the addition of human recombinant IL-2 (hrIL-2). The stimulation of IL-2 production induced by human colostrum might compensate for its inhibitory effect on NK cell activity. These findings suggest an additional mechanism by which breast feeding may affect the neonatal immune system.

Full text

PDF
F99

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold R. R., Cole M. F., McGhee J. R. A bactericidal effect for human lactoferrin. Science. 1977 Jul 15;197(4300):263–265. doi: 10.1126/science.327545. [DOI] [PubMed] [Google Scholar]
  2. Baley J. E., Schacter B. Z. Mechanisms of diminished natural killer cell activity in pregnant women and neonates. J Immunol. 1985 May;134(5):3042–3048. [PubMed] [Google Scholar]
  3. Baxter R. C., Zaltsman Z., Turtle J. R. Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk. J Clin Endocrinol Metab. 1984 Jun;58(6):955–959. doi: 10.1210/jcem-58-6-955. [DOI] [PubMed] [Google Scholar]
  4. Carpenter G. Epidermal growth factor is a major growth-promoting agent in human milk. Science. 1980 Oct 10;210(4466):198–199. doi: 10.1126/science.6968093. [DOI] [PubMed] [Google Scholar]
  5. Chirico G., Maccario R., Montagna D., Chiara A., Gasparoni A., Rondini G. Natural killer cell activity in preterm infants: effect of intravenous immune globulin administration. J Pediatr. 1990 Sep;117(3):465–466. doi: 10.1016/s0022-3476(05)81099-6. [DOI] [PubMed] [Google Scholar]
  6. Crago S. S., Mestecky J. Human colostral cells. II. Response to mitogens. Cell Immunol. 1984 Jun;86(1):222–229. doi: 10.1016/0008-8749(84)90374-5. [DOI] [PubMed] [Google Scholar]
  7. Engelhard D., Waner J. L., Kapoor N., Good R. A. Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia. J Pediatr. 1986 Jan;108(1):77–81. doi: 10.1016/s0022-3476(86)80772-7. [DOI] [PubMed] [Google Scholar]
  8. Espevik T., Waage A., Faxvaag A., Shalaby M. R. Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1 beta and transforming growth factor-beta. Cell Immunol. 1990 Mar;126(1):47–56. doi: 10.1016/0008-8749(90)90299-7. [DOI] [PubMed] [Google Scholar]
  9. Goldman A. S., Garza C., Nichols B. L., Goldblum R. M. Immunologic factors in human milk during the first year of lactation. J Pediatr. 1982 Apr;100(4):563–567. doi: 10.1016/s0022-3476(82)80753-1. [DOI] [PubMed] [Google Scholar]
  10. Hanson L. A., Ahlstedt S., Andersson B., Carlsson B., Fällström S. P., Mellander L., Porras O., Söderström T., Edén C. S. Protective factors in milk and the development of the immune system. Pediatrics. 1985 Jan;75(1 Pt 2):172–176. [PubMed] [Google Scholar]
  11. Hooton J. W., Pabst H. F., Spady D. W., Paetkau V. Human colostrum contains an activity that inhibits the production of IL-2. Clin Exp Immunol. 1991 Dec;86(3):520–524. doi: 10.1111/j.1365-2249.1991.tb02963.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Iacopetta B. J., Grieu F., Horisberger M., Sunahara G. I. Epidermal growth factor in human and bovine milk. Acta Paediatr. 1992 Apr;81(4):287–291. doi: 10.1111/j.1651-2227.1992.tb12227.x. [DOI] [PubMed] [Google Scholar]
  13. Keller M. A., Kidd R. M., Bryson Y. J., Turner J. L., Carter J. Lymphokine production by human milk lymphocytes. Infect Immun. 1981 May;32(2):632–636. doi: 10.1128/iai.32.2.632-636.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lönnerdal B. Biochemistry and physiological function of human milk proteins. Am J Clin Nutr. 1985 Dec;42(6):1299–1317. doi: 10.1093/ajcn/42.6.1299. [DOI] [PubMed] [Google Scholar]
  15. McDonald T., Sneed J., Valenski W. R., Dockter M., Cooke R., Herrod H. G. Natural killer cell activity in very low birth weight infants. Pediatr Res. 1992 Apr;31(4 Pt 1):376–380. doi: 10.1203/00006450-199204000-00014. [DOI] [PubMed] [Google Scholar]
  16. Mincheva-Nilsson L., Hammarström M. L., Juto P., Hammarström S. Human milk contains proteins that stimulate and suppress T lymphocyte proliferation. Clin Exp Immunol. 1990 Mar;79(3):463–469. doi: 10.1111/j.1365-2249.1990.tb08113.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Munoz C., Endres S., van der Meer J., Schlesinger L., Arevalo M., Dinarello C. Interleukin-1 beta in human colostrum. Res Immunol. 1990 Jul-Aug;141(6):505–513. doi: 10.1016/0923-2494(90)90019-u. [DOI] [PubMed] [Google Scholar]
  18. Nikolova E., Staykova M., Raicheva D., Karadjova M., Neronov A., Ivanov I., Goranov I. Interleukin production by human colostral cells after in vitro mitogen stimulation. Am J Reprod Immunol. 1990 Aug;23(4):104–106. doi: 10.1111/j.1600-0897.1990.tb00681.x. [DOI] [PubMed] [Google Scholar]
  19. Noda K., Umeda M., Ono T. Transforming growth factor activity in human colostrum. Gan. 1984 Feb;75(2):109–112. [PubMed] [Google Scholar]
  20. Pabst H. F., Godel J., Grace M., Cho H., Spady D. W. Effect of breast-feeding on immune response to BCG vaccination. Lancet. 1989 Feb 11;1(8633):295–297. doi: 10.1016/s0140-6736(89)91307-x. [DOI] [PubMed] [Google Scholar]
  21. Pabst H. F., Spady D. W. Effect of breast-feeding on antibody response to conjugate vaccine. Lancet. 1990 Aug 4;336(8710):269–270. doi: 10.1016/0140-6736(90)91802-h. [DOI] [PubMed] [Google Scholar]
  22. Rudloff H. E., Schmalstieg F. C., Jr, Mushtaha A. A., Palkowetz K. H., Liu S. K., Goldman A. S. Tumor necrosis factor-alpha in human milk. Pediatr Res. 1992 Jan;31(1):29–33. doi: 10.1203/00006450-199201000-00005. [DOI] [PubMed] [Google Scholar]
  23. Sancho L., de la Hera A., Casas J., Vaquer S., Martínez C., Alvarez-Mon M. Two different maturational stages of natural killer lymphocytes in human newborn infants. J Pediatr. 1991 Sep;119(3):446–454. doi: 10.1016/s0022-3476(05)82061-x. [DOI] [PubMed] [Google Scholar]
  24. Smith J. W., Schultz R. D. Mitogen- and antigen-responsive milk lymphocytes. Cell Immunol. 1977 Mar 1;29(1):165–173. doi: 10.1016/0008-8749(77)90285-4. [DOI] [PubMed] [Google Scholar]
  25. Spik G., Cheron A., Montreuil J., Dolby J. M. Bacteriostasis of a milk-sensitive strain of Escherichia coli by immunoglobulins and iron-binding proteins in association. Immunology. 1978 Oct;35(4):663–671. [PMC free article] [PubMed] [Google Scholar]
  26. Subiza J. L., Rodriguez C., Figueredo A., Mateos P., Alvarez R., de la Concha E. G. Impaired production and lack of secretion of interleukin 1 by human breast milk macrophages. Clin Exp Immunol. 1988 Mar;71(3):493–496. [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES